Sars-cov-2 immunoassay method and immunoassay kit
AssigneeSekisui Medical Co., Ltd.
InventorsJiro HIROTA, Satoru UNO, Yasushi OCHIAI, Shizuka ITO, Keisuke WATANABE, Shinya OKUYAMA, Tomohide ASAI
Life of this patent
Estimating the term…
Abstract
The present invention provides an immunoassay method for assaying SARS-CoV-2 in a biological sample, including using two types of monoclonal antibodies or antibody fragments thereof that bind to a peptide fragment having 30 or less consecutive amino acids in a nucleocapsid protein of SARS-CoV-2, wherein the two types of monoclonal antibodies or antibody fragments thereof recognize different epitopes
Claims19
An immunoassay method for assaying SARS-CoV-2 in a biological sample, comprising using two types of monoclonal antibodies or antibody fragments thereof that bind to a peptide fragment having 30 or less consecutive amino acids in a nucleocapsid protein of SARS-CoV-2, wherein the two types of monoclonal antibodies or antibody fragments thereof recognize different epitopes.
An immunoassay kit for SARS-CoV-2 in a biological sample, comprising two types of monoclonal antibodies or antibody fragments thereof that bind to a peptide fragment having 30 or less consecutive amino acids in a nucleocapsid protein of SARS-CoV-2, wherein the two types of monoclonal antibodies or antibody fragments thereof recognize different epitopes.
Dependencies are inferred from the claim text.